Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00046020
Status:
COMPLETED
Last Update Posted:
2009-08-14
First Post:
2002-09-18
Brief Title:
Study Evaluating Venlafaxine ER in Recurrent Depression
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
An Acute and Continuation Phase Study of the Comparative Efficacy Study of Venlafaxine ER Effexor XR and Fluoxetine Prozac in Achieving and Sustaining Remission Wellness in Patients With Recurrent Unipolar Major Depression Followed by a Long Term Randomized Placebo-Controlled Maintenance Treatment Study in Patients Treated Initially With Venlafaxine ER
Status:
COMPLETED
Status Verified Date:
2009-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to review the long-term comparative efficacy of venlafaxine ER in achieving and sustaining remission wellness in patients with recurrent major depression
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None